Skip to main content

BARCLAYS PLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in CAPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,623,954
-$7,945,722 QoQ
Shares Held
67,440
-78.6% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 169 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$9,492,054
PutShares
328,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,204,585 across 455 Biotechnology names. CAPR ranks #88 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CAPR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,623,954 67,440
2026-03-31 $9,569,676 314,792
2025-12-31 $9,492,054 328,900
2025-12-31 $3,445,075 119,372
2025-06-30 $934,413 94,100
2025-06-30 $1,299,944 130,911
2025-03-31 $735,939 77,549
2024-12-31 $1,237,169 89,650
2024-09-30 $552,062 36,296
2024-06-30 $83,818 17,572
2021-09-30 $25,446 6,330
2021-06-30 $9,382 1,829
2021-03-31 $458 98